As of 2025-05-13, the Fair Value of Genmab A/S (GMAB.CO) is 3,058.32 DKK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1,319.00 DKK, the upside of Genmab A/S is 131.87%.
With the market price of 1,319.00 DKK and our fair value calculation, Genmab A/S (GMAB.CO) is a good investment. Investing in GMAB.CO stocks now will result in a potential gain of 131.87%.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | 4,758.00 | 2,957.00 | 5,452.00 | 4,352.00 | 7,844.00 | 5,072.60 |
| YoY growth | 119.67% | -37.85% | 84.38% | -20.18% | 80.24% | 45.25% |
| Market Cap (mil) | 84,574.28 |
| P/E | 10.78x |
| Forward P/E | 11.22x |
| EPS | 122.33 |
| Avg earnings growth rate | 45.25% |
| TTM earnings | 7,844.00 |